Globus Medical Total Liabilities and Share Holders Equity 2010-2025 | GMED
Globus Medical total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Globus Medical total liabilities and share holders equity for the quarter ending March 31, 2025 was $4.711B, a 4.7% decline year-over-year.
- Globus Medical total liabilities and share holders equity for 2024 was $5.252B, a 3.26% increase from 2023.
- Globus Medical total liabilities and share holders equity for 2023 was $5.086B, a 144.98% increase from 2022.
- Globus Medical total liabilities and share holders equity for 2022 was $2.076B, a 6.07% increase from 2021.
| Globus Medical Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $5,252 |
| 2023 | $5,086 |
| 2022 | $2,076 |
| 2021 | $1,957 |
| 2020 | $1,679 |
| 2019 | $1,532 |
| 2018 | $1,301 |
| 2017 | $1,079 |
| 2016 | $928 |
| 2015 | $834 |
| 2014 | $704 |
| 2013 | $566 |
| 2012 | $447 |
| 2011 | $329 |
| 2010 | $267 |
| 2009 | $0 |
| Globus Medical Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4,711 |
| 2024-12-31 | $5,252 |
| 2024-09-30 | $5,086 |
| 2024-06-30 | $4,994 |
| 2024-03-31 | $4,944 |
| 2023-12-31 | $5,086 |
| 2023-09-30 | $5,356 |
| 2023-06-30 | $2,212 |
| 2023-03-31 | $2,150 |
| 2022-12-31 | $2,076 |
| 2022-09-30 | $1,977 |
| 2022-06-30 | $1,915 |
| 2022-03-31 | $1,999 |
| 2021-12-31 | $1,957 |
| 2021-09-30 | $1,911 |
| 2021-06-30 | $1,830 |
| 2021-03-31 | $1,738 |
| 2020-12-31 | $1,679 |
| 2020-09-30 | $1,542 |
| 2020-06-30 | $1,466 |
| 2020-03-31 | $1,479 |
| 2019-12-31 | $1,532 |
| 2019-09-30 | $1,452 |
| 2019-06-30 | $1,391 |
| 2019-03-31 | $1,336 |
| 2018-12-31 | $1,301 |
| 2018-09-30 | $1,239 |
| 2018-06-30 | $1,194 |
| 2018-03-31 | $1,128 |
| 2017-12-31 | $1,079 |
| 2017-09-30 | $1,037 |
| 2017-06-30 | $995 |
| 2017-03-31 | $960 |
| 2016-12-31 | $928 |
| 2016-09-30 | $902 |
| 2016-06-30 | $869 |
| 2016-03-31 | $840 |
| 2015-12-31 | $834 |
| 2015-09-30 | $801 |
| 2015-06-30 | $765 |
| 2015-03-31 | $744 |
| 2014-12-31 | $704 |
| 2014-09-30 | $646 |
| 2014-06-30 | $618 |
| 2014-03-31 | $599 |
| 2013-12-31 | $566 |
| 2013-09-30 | $525 |
| 2013-06-30 | $498 |
| 2013-03-31 | $474 |
| 2012-12-31 | $447 |
| 2012-09-30 | $416 |
| 2012-06-30 | $367 |
| 2012-03-31 | $355 |
| 2011-12-31 | $329 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $267 |
| 2009-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.982B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $193.381B | 84.70 |
| Thermo Fisher Scientific (TMO) | United States | $148.604B | 17.98 |
| Edwards Lifesciences (EW) | United States | $43.989B | 28.84 |
| Alcon (ALC) | Switzerland | $42.675B | 28.84 |
| IDEXX Laboratories (IDXX) | United States | $40.337B | 46.36 |
| DexCom (DXCM) | United States | $33.137B | 51.22 |
| STERIS (STE) | Ireland | $23.875B | 26.33 |
| IQVIA Holdings (IQV) | United States | $23.701B | 13.28 |
| Mettler-Toledo (MTD) | United States | $23.155B | 27.54 |
| Waters (WAT) | United States | $20.612B | 29.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
| Hologic (HOLX) | United States | $12.096B | 13.14 |
| Sysmex ADR (SSMXY) | Japan | $10.632B | 30.16 |
| Penumbra (PEN) | United States | $10.399B | 81.62 |
| Masimo (MASI) | United States | $8.140B | 30.03 |
| Glaukos (GKOS) | United States | $5.487B | 0.00 |
| Teleflex (TFX) | United States | $5.337B | 8.81 |
| TransMedics (TMDX) | United States | $4.203B | 91.36 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.175B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.284B | 13.60 |
| Veracyte (VCYT) | United States | $2.127B | 29.85 |
| Nihon Kohden (NHNKY) | Japan | $1.943B | 22.28 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.380B | 0.00 |
| Artivion (AORT) | United States | $1.222B | 114.44 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.956B | 5.08 |
| SiBone (SIBN) | United States | $0.783B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 32.96 |
| RxSight (RXST) | United States | $0.637B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.597B | 13.05 |
| NeuroPace (NPCE) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.569B | 8.86 |
| Delcath Systems (DCTH) | United States | $0.561B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| AxoGen (AXGN) | United States | $0.504B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.494B | 13.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.333B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.219B | 13.27 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| 908 Devices (MASS) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.90 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.67 |
| Hyperfine (HYPR) | United States | $0.042B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.58 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |